Perimeter Medical Imaging AI Announces Strong Third Quarter 2025 Financial Results
Financial Performance: Perimeter Medical Imaging AI reported a 157% increase in Q3-2025 revenue year-over-year, totaling $536,000, while operating expenses decreased by 34% compared to the previous year, leading to a net loss improvement of 42%.
Product Development: The company is advancing its next-generation Perimeter B-Series device, which incorporates AI technology, and anticipates a regulatory decision from the FDA in the first half of 2026.
Market Adoption: The Perimeter S-Series device has gained significant traction, with over 3,500 patients imaged and increasing usage among top medical centers, enhancing awareness for the upcoming B-Series.
Corporate Updates: Perimeter has made key appointments to its leadership team and established an Industry Advisory Board to support growth strategies, while also launching an OCT-Tissue Surveillance Registry to inform future product development.
About the author









